Table XII.
Reason for treatment discontinuation regarding age
| Reason for treatment discontinuation | Number (%) of discontinued treatment cycles per stopped stopped/per total treatments∗ |
|
|---|---|---|
| <40 years | ≥40 years | |
| Remission | ||
| Complete | NA | NA |
| None | 13 (19.4/12.6) | 30 (23.4/11.3) |
| Partial | 9 (13.4/8.7) | 11 (8.6/4.2) |
| No and partial | 22 (32.8/21.3) | 41 (32.9/15.5) |
| Loss of efficacy | 15 (22.4/14.6) | 25 (19.5/9.5) |
| Denial of reimbursement | 1 (1.5/0.9) | 1 (0.8/0.4) |
| Patient request | 5 (7.5/4.8) | 8 (6.3/3.0) |
| Pregnancy | NA | NA |
| Side Effect | 20 (29.9/19.4) | 41 (32.0/15.5) |
| Other | 4 (6.0/3.9) | 12 (9.4/4.5) |
| All | 67/103 | 128/264 |
NA, Not applicable.
∗
Prevalence numbers (percentages) of all patients (N = 367) regarding the reason for treatment discontinuation in patients < or ≥40 years of age at the start of therapy. The chi-square test indicates no significant differences in patients with or without psoriatic arthritis regarding sex (P = .21).